Your session is about to expire
← Back to Search
Corticosteroid
Steroid Injections for Musculoskeletal Conditions
Phase 4
Recruiting
Led By Eugene Roh, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Capable of complying with the outcome instruments used
Average pain of greater than or equal to 4/10 over the last 7 days
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at 2 weeks, 3 months, and 6 months post intervention
Awards & highlights
Study Summary
This trial will compare the effectiveness of two types of corticosteroid injections for treating pain from various musculoskeletal pathologies. It will also compare the side effect profiles of the two types of injections.
Eligible Conditions
- Tendinopathy
- Osteoarthritis
- Shoulder Impingement
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You are able to understand and complete the tests and surveys used in the study.
Select...
You have been experiencing pain that is rated 4 or higher on a scale of 0 to 10 for the past week.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and at 2 weeks, 3 months, and 6 months post intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at 2 weeks, 3 months, and 6 months post intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mean change in average pain from baseline
Secondary outcome measures
American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder Assessment Form
Conversion to surgery
Number of repeat corticosteroid injections
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Particulate Corticosteroid InjectionExperimental Treatment1 Intervention
Intra-articular, peri-tendinous, or intra-bursal corticosteroid injection using 10-80mg of triamcinolone or 3-9mg of betamethasone depending on anatomical structure. Injections may be repeated up to 3 times in the 6 month study period based on physician discretion.
Group II: Non-particulate Corticosteroid InjectionExperimental Treatment1 Intervention
Intra-articular, peri-tendinous, or intra-bursal corticosteroid injection using 4-10mg of dexamethasone depending on anatomical structure. Injections may be repeated up to 3 times in the 6 month study period based on physician discretion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexamethasone
2007
Completed Phase 4
~2590
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,729 Total Patients Enrolled
3 Trials studying Tendinopathy
55 Patients Enrolled for Tendinopathy
Eugene Roh, MD4.25 ReviewsPrincipal Investigator - Stanford University
Stanford University
5Patient Review
Dr. Roh is excellent. I sought a second opinion from him after other doctors recommended surgery for my wrist pain. He was very kind and gentle, and he took the time to examine my condition thoroughly. He explained my diagnosis in plain, simple language. After a few months of conservative treatment with Dr. Roh, I am pain free! I highly recommend Dr. Roh to all my friends!
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had previous joint surgery where a prosthetic joint was implanted.You have been experiencing pain that is rated 4 or higher on a scale of 0 to 10 for the past week.You received a corticosteroid injection in the same location within the last 3 months.You are able to understand and complete the tests and surveys used in the study.Your medical condition is not clearly diagnosed or understood.You are pregnant.You are regularly using opioids to manage your pain.You have a health condition that increases your risk for injection-related complications, such as uncontrolled diabetes, recent infection requiring antibiotics, or a tendency to bleed easily.
Research Study Groups:
This trial has the following groups:- Group 1: Particulate Corticosteroid Injection
- Group 2: Non-particulate Corticosteroid Injection
Awards:
This trial has 3 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger